The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Mar. 31, 2015
Filed:
May. 10, 2012
R. Scott Bitner, Pleasant Prairie, WI (US);
Kaitlin E. Browman, Deerfield, IL (US);
Michael E. Brune, Mundelein, IL (US);
Steven Fung, Mount Prospect, IL (US);
Peer B. Jacobson, Libertyville, IL (US);
Lynne E. Rueter, Round Lake Beach, IL (US);
Marina I. Strakhova, Vernon Hills, IL (US);
Jiahong Wang, Lake Bluff, IL (US);
Jeffrey J. Rohde, Evanston, IL (US);
Qi Shuai, Dekalb, IL (US);
James T. Link, Stanford, CA (US);
Jyoti R. Patel, Libertyville, IL (US);
Jurgen Dinges, Wadsworth, IL (US);
Bryan K. Sorensen, Antioch, IL (US);
Hong Yong, Libertyville, IL (US);
Vince S. Yeh, San Diego, CA (US);
Ravi Kurukulasuriya, East Lyme, CT (US);
R. Scott Bitner, Pleasant Prairie, WI (US);
Kaitlin E. Browman, Deerfield, IL (US);
Michael E. Brune, Mundelein, IL (US);
Steven Fung, Mount Prospect, IL (US);
Peer B. Jacobson, Libertyville, IL (US);
Lynne E. Rueter, Round Lake Beach, IL (US);
Marina I. Strakhova, Vernon Hills, IL (US);
Jiahong Wang, Lake Bluff, IL (US);
Jeffrey J. Rohde, Evanston, IL (US);
Qi Shuai, Dekalb, IL (US);
James T. Link, Stanford, CA (US);
Jyoti R. Patel, Libertyville, IL (US);
Jurgen Dinges, Wadsworth, IL (US);
Bryan K. Sorensen, Antioch, IL (US);
Hong Yong, Libertyville, IL (US);
Vince S. Yeh, San Diego, CA (US);
Ravi Kurukulasuriya, East Lyme, CT (US);
AbbVie Inc., North Chicago, IL (US);
Abstract
The present invention relates to inhibitors of the 11-beta-hydroxysteroid dehydrogenase Type 1 enzyme and their use in treatment of non-insulin dependent type 2 diabetes, insulin resistance, obesity, lipid disorders, metabolic syndrome, central nervous system disorders, and diseases and conditions that are related to excessive glucocorticoids.